Standout Papers

Beta blockade during and after myocardial infarction: An overview ... 1969 2026 1988 2007 2.4k
  1. Beta blockade during and after myocardial infarction: An overview of the randomized trials (1985)
    Salim Yusuf, Richard Peto et al. Progress in Cardiovascular Diseases
  2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. (1988)
    Peter Sleight, Sarah Parish et al. PubMed
  3. Reflex Regulation of Arterial Pressure during Sleep in Man (1969)
    Harley S. Smyth, Peter Sleight et al. Circulation Research
  4. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials (2015)
    Jordan Fulcher, Rachel O’Connell et al. The Lancet
  5. Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man (1971)
    B. Gribbin, Thomas G. Pickering et al. Circulation Research
  6. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial (2002)
    R Collins, Jane Armitage et al. The Lancet
  7. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions (2004)
    Rory Collins, Jane Armitage et al. The Lancet
  8. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial (2008)
    Salim Yusuf, K. K. Teo et al. The Lancet
  9. Changes in autonomic regulation induced by physical training in mild hypertension. (1988)
    M. Pagani, Virend K. Somers et al. Hypertension
  10. Diminished Baroreflex Sensitivity in High Blood Pressure (1969)
    James Bristow, A. J. Honour et al. Circulation
  11. Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events (2011)
    Martin O’Donnell, Salim Yusuf et al. JAMA

Immediate Impact

2 by Nobel laureates 1 from Science/Nature 116 standout
Sub-graph 1 of 17

Citing Papers

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
2017 Standout
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
2017 Standout
16 intermediate papers

Works of Peter Sleight being referenced

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
2015 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
Peter Sleight 18790 6223 3394 381 27.5k
Thomas G. Pickering 23583 6280 2490 418 35.5k
Gianfranco Parati 29424 8259 3085 980 40.3k
Guıdo Grassı 23211 4827 2280 696 31.3k
Jay N. Cohn 33891 6829 3835 526 41.6k
Michael S. Lauer 17428 4381 3631 290 25.1k
Piotr Ponikowski 29196 4524 3309 790 42.9k
Dárrel P. Francis 13930 4402 2310 394 19.2k
Robert Fagard 23167 4333 4037 464 31.9k
Henry Krum 27127 5427 1282 555 35.9k
Andrew J.S. Coats 34563 6131 8535 650 46.8k

All Works

Loading papers...

Rankless by CCL
2026